| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2397614
Max Phase: Preclinical
Molecular Formula: C28H30N2O3
Molecular Weight: 442.56
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC/C(=C(\c1ccc(O)cc1)c1ccc(NC(=O)N2CCCCC2)cc1)c1ccc(O)cc1
Standard InChI: InChI=1S/C28H30N2O3/c1-2-26(20-8-14-24(31)15-9-20)27(22-10-16-25(32)17-11-22)21-6-12-23(13-7-21)29-28(33)30-18-4-3-5-19-30/h6-17,31-32H,2-5,18-19H2,1H3,(H,29,33)/b27-26+
Standard InChI Key: UMOYHUFFASXCSK-CYYJNZCTSA-N
Associated Targets(Human)
DNA topoisomerase I 7553 Activities
DNA topoisomerase II alpha 6317 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MSTO-211H 316 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HeLa 62764 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MCF7 126967 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 442.56 | Molecular Weight (Monoisotopic): 442.2256 | AlogP: 6.48 | #Rotatable Bonds: 5 |
| Polar Surface Area: 72.80 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 9.07 | CX Basic pKa: | CX LogP: 6.09 | CX LogD: 6.08 |
| Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.40 | Np Likeness Score: -0.54 |
References
| 1. Christodoulou MS, Fokialakis N, Passarella D, García-Argáez AN, Gia OM, Pongratz I, Dalla Via L, Haroutounian SA.. (2013) Synthesis and biological evaluation of novel tamoxifen analogues., 21 (14): [PMID:23735829] [10.1016/j.bmc.2013.05.012] |
Source
Source(1):